Clinical Trial Myth #1: Clinical Trials Are Dangerous
Hear from David Kelleher, the CEO and co-founder of 4G Clinical, on patient safety in clinical trials.
Clinical Trial Myth #2:
If You Take Part, You Won't Be Helped
Watch Joseph Kim from Eli Lilly and Company address the different potential outcomes patients may face.
Clinical Trial Myth #3:
I Might Get A "Sugar Pill" or Placebo
Hear from T.J. Sharpe, a Melanoma Survivor and Patient Advisor, on the truths about sugar pills, standard of care and the placebo affect.
Clinical Trial Myth #4:
If You Try To Get In, You Won't Be Eligible
Watch Joseph Kim from Eli Lilly and Company discuss patient eligibility and the need for strict criteria within the enrollment process.
What advice would you give a sponsor looking to be more site centric?
Hear from Christina Brennan, M.D., Vice President, Clinical Research at Northwell Health, and Natasha Phrsai, BS, MBA, Director, Investigator Support at Northwell Health.
How open are you to innovation and what does innovation look like to you?
Hear Roger DeRaad, MN, CNP, Director of Research at Black Hills Cardiovascular Research, speak about the challenges of innovation and the need for flexibility among site users.
What is your biggest pain point in inventory and supply management at your site?
Hear from Jeff Burmeister, PharmD, CCRP, Clinical Research/Investigational Pharmacist at Dignity Health at St. Joseph’s Hospital & Medical Center.
If you could influence RTSM design, what would you change?
Hear Stephanie Abbot, Pharm D., Research Director at Western Washington Medical Group, speak on how clinical systems can improve to better manage drug accountability.
What advice would you give a sponsor looking to be more site centric?
Hear Amanda Benoit, a Clinical Research Coordinator, provide insight on how trial sponsors can become more site centric.
How open are you to innovation and what does innovation look like to you?
Sashi Makam, M.D., Founder and Principle Investigator at Mid Hudson Medical Research, shares his views on innovation.
If you could influence RTSM design, what would you change?
Hear from Jeff Burmeister, PharmD, CCRP, Clinical Research/Investigational Pharmacist at Dignity Health at St. Joseph’s Hospital & Medical Center.
Sponsors are Transitioning to Direct-to-Patient Trials – Are you Prepared?
In this podcast, 4G Clinical's Senior Director of Strategy, Neta Bendelac, speaks with SCRC to discuss how sites can prepare for Direct-to-Patient trials.
Modern Technology has Enabled Speed, Flexibility and Robust Quality in Clinical Trials